{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T04:03:24Z","timestamp":1792814604377,"version":"4.5.0"},"reference-count":39,"publisher":"Impact Journals, LLC","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2017,1,31]]},"DOI":"10.18632\/oncotarget.14373","type":"journal-article","created":{"date-parts":[[2017,1,3]],"date-time":"2017-01-03T12:40:46Z","timestamp":1483447246000},"page":"8622-8632","source":"Crossref","is-referenced-by-count":36,"title":["Targeting P-glycoprotein function, p53 and energy metabolism: Combination of metformin and 2-deoxyglucose reverses the multidrug resistance of MCF-7\/Dox cells to doxorubicin"],"prefix":"10.18632","volume":"8","author":[{"given":"Chaojun","family":"Xue","sequence":"first","affiliation":[{"name":"Department of Clinical Pharmacology, College of Pharmacy, Dalian Medical University, Dalian, China"},{"name":"Department of Pharmacy, Hebei General Hospital, Shijiazhuang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changyuan","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacology, College of Pharmacy, Dalian Medical University, Dalian, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaoting","family":"Sun","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacology, College of Pharmacy, Dalian Medical University, Dalian, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Meng","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacology, College of Pharmacy, Dalian Medical University, Dalian, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhihao","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacology, College of Pharmacy, Dalian Medical University, Dalian, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaokui","family":"Huo","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacology, College of Pharmacy, Dalian Medical University, Dalian, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pengyuan","family":"Sun","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacology, College of Pharmacy, Dalian Medical University, Dalian, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huijun","family":"Sun","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacology, College of Pharmacy, Dalian Medical University, Dalian, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaodong","family":"Ma","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacology, College of Pharmacy, Dalian Medical University, Dalian, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaochi","family":"Ma","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacology, College of Pharmacy, Dalian Medical University, Dalian, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinyong","family":"Peng","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacology, College of Pharmacy, Dalian Medical University, Dalian, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kexin","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacology, College of Pharmacy, Dalian Medical University, Dalian, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2016,12,30]]},"reference":[{"issue":"65","key":"1","doi-asserted-by":"publisher","first-page":"87","DOI":"10.3322\/caac.21262","article-title":"Global cancer statistics, 2012","volume":"2015","author":"Jemal","journal-title":"CA Cancer J Clin"},{"issue":"38","key":"2","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1016\/j.ctrv.2012.02.011","article-title":"Taxane resistance in breast cancer: mechanisms, predictive biomarkers and circumvention strategies","volume":"2012","author":"Papadimitriou","journal-title":"Cancer Treat Rev"},{"issue":"15","key":"3","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.drup.2012.02.002","article-title":"Targeting MDR in breast and lung cancer: discriminating its potential importance from the failure of drug resistance reversal studies","volume":"2012","author":"Bates","journal-title":"Drug Resist Updat"},{"issue":"18","key":"4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.drup.2014.11.002","article-title":"The modulation of ABC transporter-mediated multidrug resistance in cancer: A review of the past decade","volume":"2015","author":"Chen","journal-title":"Drug Resist Updat"},{"issue":"596","key":"5","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/978-1-60761-416-6_4","article-title":"Mechanisms of multidrug resistance in cancer","volume":"2010","author":"Gottesman","journal-title":"Methods Mol Biol"},{"issue":"149","key":"6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.pharmthera.2014.11.013","article-title":"Modulation of P-glycoprotein efflux pump: induction and activation as a therapeutic strategy","volume":"2015","author":"Remiao","journal-title":"Pharmacol Ther"},{"issue":"56","key":"7","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1146\/annurev-pharmtox-010715-103111","article-title":"Toward a Better Understanding of the Complexity of Cancer Drug Resistance","volume":"2016","author":"Gillet","journal-title":"Annu Rev Pharmacol Toxicol"},{"issue":"99","key":"8","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.critrevonc.2015.11.019","article-title":"TP53 and MDM2 genetic alterations in non-small cell lung cancer: Evaluating their prognostic and predictive value","volume":"2016","author":"Pauwels","journal-title":"Crit Rev Oncol Hematol"},{"issue":"22","key":"9","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1038\/cdd.2015.53","article-title":"TP53: an oncogene in disguise","volume":"2015","author":"Wiman","journal-title":"Cell Death Differ"},{"key":"10","doi-asserted-by":"publisher","first-page":"20691","DOI":"10.18632\/oncotarget.7842","article-title":"Repeated PM2.5 exposure inhibits BEAS-2B cell P53 expression through ROS-Akt-DNMT3B pathway-mediated promoter hypermethylation","volume":"7","author":"Yuan","year":"2016","journal-title":"Oncotarget"},{"key":"11","doi-asserted-by":"publisher","first-page":"11817","DOI":"10.18632\/oncotarget.7857","article-title":"Cancer therapeutic approach based on conformational stabilization of mutant p53 protein by small peptides","volume":"7","author":"Rotter","year":"2016","journal-title":"Oncotarget"},{"issue":"70","key":"12","doi-asserted-by":"publisher","first-page":"2465","DOI":"10.1158\/0008-5472.can-09-2782","article-title":"et al.Targeting cancer cell metabolism: the combination of metformin and 2-deoxyglucose induces p53-dependent apoptosis in prostate cancer cells","volume":"2010","author":"Tanti","journal-title":"Cancer Res"},{"issue":"77","key":"13","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1007\/s00280-015-2944-z","article-title":"p53 overexpression increases chemosensitivity in multidrug-resistant osteosarcoma cell lines","volume":"2016","author":"Duan","journal-title":"Cancer Chemother Pharmacol"},{"key":"14","first-page":"309","volume-title":"Science","volume":"1956","author":"Warburg"},{"issue":"5","key":"15","doi-asserted-by":"publisher","first-page":"e188","DOI":"10.1038\/oncsis.2015.46","article-title":"Energy disruptors: rising stars in anticancer therapy?","volume":"2016","author":"Clavel","journal-title":"Oncogenesis"},{"issue":"2","key":"16","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1038\/nrc706","article-title":"Multidrug resistance in cancer: role of ATP-dependent transporters","volume":"2002","author":"Bates","journal-title":"Nat Rev Cancer"},{"issue":"136","key":"17","doi-asserted-by":"publisher","first-page":"E188","DOI":"10.1002\/ijc.29158","article-title":"Sweat but no gain: inhibiting proliferation of multidrug resistant cancer cells with \u201cersatzdroges\u201d","volume":"2015","author":"Gatenby","journal-title":"Int J Cancer"},{"issue":"37","key":"18","doi-asserted-by":"publisher","first-page":"8587","DOI":"10.1007\/s13277-015-4478-8","article-title":"Targeting P-glycoprotein expression and cancer cell energy metabolism: combination of metformin and 2-deoxyglucose reverses the multidrug resistance of K562\/Dox cells to doxorubicin","volume":"2016","author":"Liu","journal-title":"Tumour Biol"},{"issue":"16","key":"19","doi-asserted-by":"publisher","first-page":"106","DOI":"10.4161\/15384047.2014.987062","article-title":"Dasatinib reverses the multidrug resistance of breast cancer MCF-7 cells to doxorubicin by downregulating P-gp expression via inhibiting the activation of ERK signaling pathway","volume":"2015","author":"Liu","journal-title":"Cancer Biol Ther"},{"issue":"103","key":"20","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1038\/sj.bjc.6605912","article-title":"How Darwinian models inform therapeutic failure initiated by clonal heterogeneity in cancer medicine","volume":"2010","author":"Swanton","journal-title":"Br J Cancer"},{"key":"21","first-page":"23","volume-title":"Science","volume":"1976","author":"Nowell"},{"key":"22","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1002\/cncr.29912","article-title":"Metformin prevents hepatocellular carcinoma development by suppressing hepatic progenitor cell activation in a rat model of cirrhosis","volume":"122","author":"Fuchs","year":"2016","journal-title":"Cancer"},{"issue":"37","key":"23","doi-asserted-by":"publisher","first-page":"11199","DOI":"10.1007\/s13277-016-5007-0","article-title":"Metformin and AICAR regulate NANOG expression via the JNK pathway in HepG2 cells independently of AMPK","volume":"2016","author":"Park","journal-title":"Tumour Biol"},{"issue":"467","key":"24","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.bbrc.2015.09.106","article-title":"Identification of the determinants of 2-deoxyglucose sensitivity in cancer cells by shRNA library screening","volume":"2015","author":"Yoshida","journal-title":"Biochem Biophys Res Commun"},{"issue":"8","key":"25","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1242\/dmm.021667","article-title":"Glycolytic inhibitor 2-deoxyglucose simultaneously targets cancer and endothelial cells to suppress neuroblastoma growth in mice","volume":"2015","author":"Chuang","journal-title":"Dis Model Mech"},{"issue":"162","key":"26","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1111\/j.1476-5381.2010.01101.x","article-title":"Metformin inhibits P-glycoprotein expression via the NF-kappaB pathway and CRE transcriptional activity through AMPK activation","volume":"2011","author":"Jeong","journal-title":"Br J Pharmacol"},{"issue":"50","key":"27","first-page":"544","article-title":"Effects of 2-deoxyglucose on drug-sensitive and drug-resistant human breast cancer cells: toxicity and magnetic resonance spectroscopy studies of metabolism","volume":"1990","author":"Cohen","journal-title":"Cancer Res"},{"issue":"101","key":"28","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.bcp.2015.12.007","article-title":"Drug-protein hydrogen bonds govern the inhibition of the ATP hydrolysis of the multidrug transporter P-glycoprotein","volume":"2016","author":"Ambudkar","journal-title":"Biochem Pharmacol"},{"key":"29","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1016\/j.ctrv.2012.12.001","article-title":"Targeting triple negative breast cancer: is p53 the answer?","volume":"39","author":"Di Leo","journal-title":"Cancer Treat Rev"},{"issue":"1","key":"30","first-page":"1001","article-title":"The MDM2-p53 interaction","volume":"2003","author":"Petrenko","journal-title":"Mol Cancer Res"},{"issue":"40","key":"31","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1016\/j.ctrv.2014.10.004","article-title":"p53 as a target for the treatment of cancer","volume":"2014","author":"Gallagher","journal-title":"Cancer Treat Rev"},{"key":"32","doi-asserted-by":"publisher","first-page":"12951","DOI":"10.18632\/oncotarget.7339","article-title":"Targeting the p53-MDM2 interaction by the small-molecule MDM2 antagonist Nutlin-3a: a new challenged target therapy in adult Philadelphia positive acute lymphoblastic leukemia patients","volume":"7","author":"Cattina","year":"2016","journal-title":"Oncotarget"},{"issue":"63","key":"33","first-page":"7284","article-title":"Glucose depletion enhances P-glycoprotein expression in hepatoma cells: role of endoplasmic reticulum stress response","volume":"2003","author":"Laouari","journal-title":"Cancer Res"},{"issue":"16","key":"34","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1096\/fj.02-0541com","article-title":"Characterization of a novel metabolic strategy used by drug-resistant tumor cells","volume":"2002","author":"Bespalov","journal-title":"FASEB J"},{"issue":"10","key":"35","doi-asserted-by":"publisher","first-page":"2350","DOI":"10.1158\/1535-7163.MCT-11-0497","article-title":"Dual inhibition of tumor energy pathway by 2-deoxyglucose and metformin is effective against a broad spectrum of preclinical cancer models","volume":"2011","author":"Ajani","journal-title":"Mol Cancer Ther"},{"issue":"6","key":"36","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1158\/0008-5472.can-09-2782","article-title":"The combination of metformin and 2-deoxyglucose inhibits autophagy and induces AMPK-dependent apoptosis in prostate cancer cells","volume":"2010","author":"Bost","journal-title":"Autophagy"},{"issue":"66","key":"37","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1146\/annurev-med-062613-093128","article-title":"Metformin in cancer treatment and prevention.Annu","volume":"2015","author":"Morris","journal-title":"Rev Med"},{"issue":"519","key":"38","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1038\/nature14107","article-title":"SLC38A9 is a component of the lysosomal amino acid sensing machinery that controls mTORC1","volume":"2015","author":"Huber","journal-title":"Nature"},{"issue":"64","key":"39","doi-asserted-by":"publisher","first-page":"3892","DOI":"10.1158\/0008-5472.can-03-2904","article-title":"Akt stimulates aerobic glycolysis in cancer cells","volume":"2004","author":"Thompson","journal-title":"Cancer Res"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.14373","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,10]],"date-time":"2020-05-10T16:20:31Z","timestamp":1589127631000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.14373"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12,30]]},"references-count":39,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017,1,31]]}},"alternative-id":["14373","28052008"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.14373","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,12,30]]}}}